Genmab A/S Proceeds From Sales Of Investments Accounted For Using Equity Method
Genmab A/S (GMAB) reported Proceeds From Sales Of Investments Accounted For Using Equity Method of DKK 438.00 million for the 12-month period ending 2021-12-31, per its 6-K filed 2024-02-14.
Discontinued › Cash Flow
ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod · last filed 2024-02-14
| Period end | Proceeds From Sales Of Investments Accounted For Using Equity Method 6 month | Proceeds From Sales Of Investments Accounted For Using Equity Method 12 month |
|---|---|---|
| 2021-12-31 | 438.00M DKK 6-K · filed 2024-02-14 | |
| 2021-06-30 | 438.00M DKK 6-K · filed 2022-08-10 |